Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Color Doppler of CL and Uterine Artery With Serum Progesterone and CA125 in Threatened Abortion

NCT02420769 is registered in ClinicalTrials.gov with Nesreen Abdel Fattah Abdullah Shehata as lead sponsor.

NCT NCT02420769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Color Doppler of CL and Uterine Artery With Serum Progesterone and CA125 in Threatened Abortion
Lead sponsor
Nesreen Abdel Fattah Abdullah Shehata
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
May 31, 2017
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

threatened abortion